
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pritelivir
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : AiCuris
Deal Size : Undisclosed
Deal Type : Collaboration
AiCuris collaborates with myTomorrows
Details : The companies are collaborating to develop an Early Access Program for pritelivir, for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
February 12, 2020
Lead Product(s) : Pritelivir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : AiCuris
Deal Size : Undisclosed
Deal Type : Collaboration
